Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
29
pubmed:dateCreated
2006-10-9
pubmed:abstractText
Recent reports suggest that cancer control may worsen if erythropoietin is administered. We investigated whether erythropoietin receptor expression on cancer cells may correlate with this unexpected finding.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1527-7755
pubmed:author
pubmed:issnType
Electronic
pubmed:day
10
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4708-13
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:17028293-Adult, pubmed-meshheading:17028293-Aged, pubmed-meshheading:17028293-Aged, 80 and over, pubmed-meshheading:17028293-Carcinoma, pubmed-meshheading:17028293-Disease Progression, pubmed-meshheading:17028293-Erythropoietin, pubmed-meshheading:17028293-Female, pubmed-meshheading:17028293-Gene Expression Profiling, pubmed-meshheading:17028293-Head and Neck Neoplasms, pubmed-meshheading:17028293-Humans, pubmed-meshheading:17028293-Immunohistochemistry, pubmed-meshheading:17028293-Male, pubmed-meshheading:17028293-Middle Aged, pubmed-meshheading:17028293-Prognosis, pubmed-meshheading:17028293-Randomized Controlled Trials as Topic, pubmed-meshheading:17028293-Receptors, Erythropoietin, pubmed-meshheading:17028293-Recombinant Proteins, pubmed-meshheading:17028293-Retrospective Studies, pubmed-meshheading:17028293-Survival Analysis, pubmed-meshheading:17028293-Treatment Outcome
pubmed:year
2006
pubmed:articleTitle
Do erythropoietin receptors on cancer cells explain unexpected clinical findings?
pubmed:affiliation
Klinik für Strahlenheilkunde, Universitätsklinikum, Robert Koch Strasse, 3 D-79106, Freiburg, Germany. henke@uni-freiburg.de
pubmed:publicationType
Journal Article